SUSQUEHANNA INTERNATIONAL GROUP, LLP - PASITHEA THERAPEUTICS CORP ownership

PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F111. A total of 6 filers reported holding PASITHEA THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PASITHEA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$2,000
+100.0%
10,653
-22.8%
0.00%
Q2 2022$1,00013,8030.00%
Other shareholders
PASITHEA THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Warberg Asset Management LLC 311,183$20,0000.00%
Kepos Capital LP 334,600$22,0000.00%
ARMISTICE CAPITAL, LLC 1,000,000$65,0000.00%
UBS Group AG 1,599$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,803$1,0000.00%
View complete list of PASITHEA THERAPEUTICS CORP shareholders